About Telix Pharmaceuticals
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Company Highlights
Year Founded
2015
Employees
431
Location (HQ)
AUS
Since Last Funding
2 years 5 months
Monthly Website Visitors
34.4K
Total Investment Amt
$64M
MoM Headcount Growth
3.36%
YoY Headcount Growth
40.38%
Key Metrics
Senior Hires
Name | Linkedin Profile | Position | Date Joined |
---|---|---|---|
John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- AVATAMEDCurie TherapeuticsRefleXion MedicalTango TherapeuticsRayzeBioNurix TherapeuticsTerns PharmaceuticalsX4 PharmaceuticalsPoint BiopharmaZentalis PharmaceuticalsStemcentrxBrooklyn ImmunoTherapeuticsAktis OncologyLantern PharmaOn Target LaboratoriesTESAROEloxxGT Medical TechnologiesTentarix BiotherapeuticsTELA BioTAE Life SciencesRibometrixSalarius PharmaceuticalsRainier TherapeuticsIterion TherapeuticsSapience TherapeuticsTuring PharmaceuticalsTorigen PharmaceuticalsLB PharmaceuticalsXTuit PharmaceuticalsTelo TherapeuticsAzeria TherapeuticsMAIA BiotechnologyStelexis TherapeuticsCellix BioTolero PharmaceuticalsBAKX TherapeuticsRadiance TherapeuticsTelsar PharmaCyterix PharmaceuticalsTensha TherapeuticsFocus-X TherapeuticsTeclisonRepare TherapeuticsFusion PharmaceuticalsBiolineRxNeoTX TherapeuticsPurple BiotechKintara TherapeuticsLixte Biotechnology HoldingsInspyr TherapeuticsStarget Pharma Ltd.Kesios TherapeuticsTetraphase PharmaceuticalsPhoenix BiotechnologyPhoenix Molecular DesignsTerapioTigris PharmaceuticalsAriceum TherapeuticsPrecirixTOLREMO therapeuticsT3 PharmaceuticalsTelum TherapeuticsTheranexusIxaltisTenboronCTI BioPharmaTranscode TherapeuticsTheralink TechnologiesGilead SciencesExelixisIdrxTrial LibraryAdvanCellBivisionTauRx PharmaceuticalsRadioMedixTeligeneEutilexAblaze PharmaceuticalsBraizon Therapeutics, Inc.Shenzhen TargetRxCantex PharmaceuticalsCylene PharmaceuticalsLytix BiopharmaRatio TherapeuticsTachyon TherapeuticsTellus TherapeuticsLTZ TherapeuticsEtiraRxNucleus RadioPharmaLutris PharmaPlexxikonTargetRxPintex PharmaceuticalsSemafore PharmaceuticalsTrevarx BiomedicalShuttle PharmaceuticalsGaluxTIRmed PharmaVitarka TherapeuticsZTI BiosciencesBioCurity PharmaceuticalsLinaTechReglageneTelis BioscienceTollysTetraKit TechnologiesSignalRx PharmaceuticalsAblatus TherapeuticsAptadel TherapeuticsNERx BiosciencesTheraCea PharmaSabik MedicalTIESRxXello AustraliaXTEK LimitedCalytrix TechnologiesAlutix Insulationxilix systems llc.TellextTecnilab,SASILEXTelrex (Australia)CentixTorxennEtexTelexar TechnologiesTIAX LLCRadiology Ltd.Lunarix GmbHIRX AdvisorsTKXS by TELUS AgricultureTitan Minerals Ltd (ASX:TTM)Tees Valley Lithium Ltd
Biotechnology
Biotechnology Research